Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: results of a prospective randomized multicenter study (SENATOR)
Early conversion to everolimus was assessed in kidney transplant recipients participating in the Eurotransplant Senior Program (ESP), a population in whom data are lacking. The SENATOR multicenter study enrolled 207 kidney transplant recipients undergoing steroid withdrawal at week 2 post-transplant...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 19, 2019
|
| In: |
PLOS ONE
Year: 2019, Volume: 14, Issue: 9 |
| ISSN: | 1932-6203 |
| DOI: | 10.1371/journal.pone.0222730 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0222730 Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0222730 
|
| Author Notes: | Susanne Brakemeier, Wolfgang Arns, Frank Lehner, Oliver Witzke, Oliver Vonend, Claudia Sommerer, Anja Mühlfeld, Thomas Rath, Robert Schuhmann, Bianca Zukunft, Irena Kroeger, Martina Porstner, Klemens Budde |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694421279 | ||
| 003 | DE-627 | ||
| 005 | 20220818035425.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200414s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0222730 |2 doi | |
| 035 | |a (DE-627)1694421279 | ||
| 035 | |a (DE-599)KXP1694421279 | ||
| 035 | |a (OCoLC)1341314645 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Brakemeier, Susanne |d 1971- |e VerfasserIn |0 (DE-588)123231795 |0 (DE-627)706219139 |0 (DE-576)293614709 |4 aut | |
| 245 | 1 | 0 | |a Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program |b results of a prospective randomized multicenter study (SENATOR) |c Susanne Brakemeier, Wolfgang Arns, Frank Lehner, Oliver Witzke, Oliver Vonend, Claudia Sommerer, Anja Mühlfeld, Thomas Rath, Robert Schuhmann, Bianca Zukunft, Irena Kroeger, Martina Porstner, Klemens Budde |
| 264 | 1 | |c September 19, 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.04.2020 | ||
| 520 | |a Early conversion to everolimus was assessed in kidney transplant recipients participating in the Eurotransplant Senior Program (ESP), a population in whom data are lacking. The SENATOR multicenter study enrolled 207 kidney transplant recipients undergoing steroid withdrawal at week 2 post-transplant (ClinicalTrials.gov [NCT00956293]). At week 7, patients were randomized (1:2 ratio) to continue the previous calcineurin inhibitor (CNI)-based regimen with mycophenolic acid (MPA) and cyclosporine or switch to a CNI-free regimen with MPA, everolimus (5-10 ng/mL) and basiliximab at weeks 7 and 12, then followed for 18 weeks to month 6 post-transplant. The primary endpoint was estimated GFR (eGFR). At week 7, 77/207 (37.2%) patients were randomized (53 everolimus, 24 control). At month 6, eGFR was comparable: 36.5±10.8ml/min with everolimus versus 42.0±13.0ml/min in the control group (p = 0.784). Discontinuation due to adverse events occurred in 27.8% of everolimus-treated patients and 0.0% of control patients (p = 0005). Efficacy profiles showed no difference. In conclusion, eGFR, safety and efficacy outcomes at month 6 post-transplant showed no difference between groups. The everolimus group experienced a higher rate of discontinuation due to adverse events. However, the high rate of non-randomization is highly relevant, indicating this to be a somewhat unstable patient population regardless of treatment. | ||
| 650 | 4 | |a Adverse events | |
| 650 | 4 | |a Creatinine | |
| 650 | 4 | |a Elderly | |
| 650 | 4 | |a Geriatrics | |
| 650 | 4 | |a Immunosuppressives | |
| 650 | 4 | |a Renal system | |
| 650 | 4 | |a Renal transplantation | |
| 650 | 4 | |a Steroids | |
| 700 | 1 | |a Arns, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lehner, Frank |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witzke, Oliver |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vonend, Oliver |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sommerer, Claudia |d 1971- |e VerfasserIn |0 (DE-588)121857654 |0 (DE-627)705680002 |0 (DE-576)292921829 |4 aut | |
| 700 | 1 | |a Mühlfeld, Anja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rath, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schuhmann, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zukunft, Bianca |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kroeger, Irena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Porstner, Martina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Budde, Klemens |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLOS ONE |d San Francisco, California, US : PLOS, 2006 |g 14(2019,9) Artikel-Nummer e0222730, 17 Seiten |h Online-Ressource |w (DE-627)523574592 |w (DE-600)2267670-3 |w (DE-576)281331979 |x 1932-6203 |7 nnas |a Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program results of a prospective randomized multicenter study (SENATOR) |
| 773 | 1 | 8 | |g volume:14 |g year:2019 |g number:9 |a Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program results of a prospective randomized multicenter study (SENATOR) |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0222730 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0222730 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200414 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 121857654 |a Sommerer, Claudia |m 121857654:Sommerer, Claudia |d 50000 |e 50000PS121857654 |k 0/50000/ |p 6 | ||
| 999 | |a KXP-PPN1694421279 |e 362258842X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1694421279","note":["Gesehen am 14.04.2020"],"name":{"displayForm":["Susanne Brakemeier, Wolfgang Arns, Frank Lehner, Oliver Witzke, Oliver Vonend, Claudia Sommerer, Anja Mühlfeld, Thomas Rath, Robert Schuhmann, Bianca Zukunft, Irena Kroeger, Martina Porstner, Klemens Budde"]},"relHost":[{"id":{"eki":["523574592"],"issn":["1932-6203"],"zdb":["2267670-3"]},"disp":"Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program results of a prospective randomized multicenter study (SENATOR)PLOS ONE","language":["eng"],"recId":"523574592","note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"name":{"displayForm":["Public Library of Science"]},"physDesc":[{"extent":"Online-Ressource"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"Public Library of Science"}],"title":[{"title":"PLOS ONE","title_sort":"PLOS ONE"}],"part":{"text":"14(2019,9) Artikel-Nummer e0222730, 17 Seiten","issue":"9","year":"2019","volume":"14"},"origin":[{"publisher":"PLOS ; PLoS","dateIssuedKey":"2006","publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedDisp":"2006-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2006 -"]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","display":"Brakemeier, Susanne","given":"Susanne","roleDisplay":"VerfasserIn","family":"Brakemeier"},{"family":"Arns","roleDisplay":"VerfasserIn","given":"Wolfgang","display":"Arns, Wolfgang","role":"aut"},{"given":"Frank","family":"Lehner","roleDisplay":"VerfasserIn","display":"Lehner, Frank","role":"aut"},{"display":"Witzke, Oliver","role":"aut","family":"Witzke","roleDisplay":"VerfasserIn","given":"Oliver"},{"display":"Vonend, Oliver","role":"aut","given":"Oliver","family":"Vonend","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Sommerer, Claudia","family":"Sommerer","roleDisplay":"VerfasserIn","given":"Claudia"},{"roleDisplay":"VerfasserIn","family":"Mühlfeld","given":"Anja","role":"aut","display":"Mühlfeld, Anja"},{"display":"Rath, Thomas","role":"aut","given":"Thomas","family":"Rath","roleDisplay":"VerfasserIn"},{"given":"Robert","roleDisplay":"VerfasserIn","family":"Schuhmann","role":"aut","display":"Schuhmann, Robert"},{"role":"aut","display":"Zukunft, Bianca","roleDisplay":"VerfasserIn","family":"Zukunft","given":"Bianca"},{"roleDisplay":"VerfasserIn","family":"Kroeger","given":"Irena","display":"Kroeger, Irena","role":"aut"},{"given":"Martina","family":"Porstner","roleDisplay":"VerfasserIn","role":"aut","display":"Porstner, Martina"},{"role":"aut","display":"Budde, Klemens","roleDisplay":"VerfasserIn","family":"Budde","given":"Klemens"}],"language":["eng"],"origin":[{"dateIssuedDisp":"September 19, 2019","dateIssuedKey":"2019"}],"id":{"eki":["1694421279"],"doi":["10.1371/journal.pone.0222730"]},"title":[{"title":"Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program","title_sort":"Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program","subtitle":"results of a prospective randomized multicenter study (SENATOR)"}]} | ||
| SRT | |a BRAKEMEIEREVEROLIMUS1920 | ||